(thirdQuint)Dose-Finding Trial With Sugammadex at 3 and 15 Minutes After 1.

0 and 1.

2 mg/kg Rocuronium Bromide in Subjects of ASA Class 1-3 (19.

4.

206)(P05944).

 In the US the highest dose recommended in the package insert of Zemuron(R) (i.

e.

 the trade name for Esmeron(R) in the US) is 1.

2 mg/kg whereas in Europe it is 1.

0 mg/kg.

 For both doses, dose recommendations for reversal with Org 25969 were to be found.

 Hence, the present trial was set up to explore the dose-response relation of Org 25969 given as a reversal agent at 3 and 15 minutes following administration of 1.

0 and 1.

2 mg/kg of Esmeron(R) in subjects of ASA 1 to 3.

 The sub-investigator who performed any subjective safety assessments after anesthesia was to be remained blinded.

.

 Dose-Finding Trial With Sugammadex at 3 and 15 Minutes After 1.

0 and 1.

2 mg/kg Rocuronium Bromide in Subjects of ASA Class 1-3 (19.

4.

206)(P05944)@highlight

The objective of the trial was to explore the dose-response relation of Org 25969 given as a reversal agent at 3 and 15 minutes following administration of 1.

0 and 1.

2 mg/kg of Esmeron(R) (rocuronium) in subjects of ASA 1 to 3, and to evaluate the safety of single doses of Org 25969 administered to subjects of ASA 1 to 3.

